Overview
Emmanuelle Trombe, Anthony Paronneau, Raphaëlle Monjou and Louise Aberg advised France’s Servier, an international pharmaceutical company, in its license option agreement with OSE Immunotherapeutics on the exclusive worldwide rights to commercialize a monoclonal immunomodulatory antibody.
